-
Therapeutic strategies in epithelial ovarian cancer.
Journal of experimental & clinical cancer research : CR 20120101
-
A data-driven predictive approach for drug delivery using machine learning techniques.
PloS one 20120101
-
Increased nephrotoxicity after combined administration of melamine and cyanuric Acid in rats.
Laboratory animal research 20110301
-
Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube.
International journal of nanomedicine 20110101
-
Concordance of self-reported and medical chart information on cancer diagnosis and treatment.
BMC medical research methodology 20110101
-
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.
International journal of nanomedicine 20110101
-
Brain metastases from ovarian carcinoma.
ISRN oncology 20110101
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation.
Drug delivery 20100401
-
Cancer-drug associations: a complex system.
PloS one 20100101
-
Clinical trials and progress with paclitaxel in ovarian cancer.
International journal of women's health 20100101
-
Hexamethylmelamine as consolidation treatment for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy.
Journal of Korean medical science 20090801
-
Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.
Journal of ovarian research 20090101
-
Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
Cancer chemotherapy and pharmacology 20081201
-
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal of medicinal chemistry 20081113
-
Relationship between frailty and cognitive decline in older Mexican Americans.
Journal of the American Geriatrics Society 20081001
-
Atom efficient cyclotrimerization of dimethylcyanamide catalyzed by aluminium amide: a combined experimental and theoretical investigation.
Chemical communications (Cambridge, England) 20080821
-
Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701
-
Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines.
Bioorganic & medicinal chemistry letters 20070615
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Pretreatment CA-125 and risk of relapse in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320
-
Topotecan: weighing in when there are many options.
The oncologist 20051001
-
Better treatments improve survival of CHD patients.
The Nurse practitioner 20050901
-
Emerging drugs for ovarian cancer.
Expert opinion on emerging drugs 20050501
-
Recurrent ovarian cancer: how important is it to treat to disease progression?
Clinical cancer research : an official journal of the American Association for Cancer Research 20041115
-
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
British journal of cancer 20040517
-
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.
British journal of cancer 20040223
-
Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?
British journal of cancer 20040126
-
Oral altretamine used as salvage therapy in recurrent ovarian cancer.
Gynecologic oncology 20040101
-
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20040101
-
Oral melphalan as a treatment for platinum-resistant ovarian cancer.
British journal of cancer 20030616
-
Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study.
Gynecologic oncology 20030201
-
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.
BMC cancer 20030101
-
Medication sheets for patients. Oral chemotherapy.
Clinical journal of oncology nursing 20030101
-
Oral cancer treatment: developments in chemotherapy and beyond.
British journal of cancer 20021021
-
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease.
The Lancet. Oncology 20020901
-
A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site.
British journal of cancer 20020422
-
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
The Journal of biological chemistry 20020419
-
Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine.
Journal of microencapsulation 20020101
-
Recent advances in the treatment of epithelial ovarian cancer.
Expert opinion on investigational drugs 20010901
-
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).
Gynecologic oncology 20010801
-
A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer.
Cancer chemotherapy and pharmacology 20010801
-
Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinoma.
Gynecologic oncology 20010401
-
Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer.
Japanese journal of clinical oncology 20010201
-
Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.
Investigational new drugs 20010101
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Health technology assessment (Winchester, England) 20010101
-
Clinical pharmacokinetics of altretamine.
Clinical pharmacokinetics 19950601
-
The w/w+ SMART is a useful tool for the evaluation of pesticides.
Mutagenesis 19940701
-
Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin.
Cancer 19901015
-
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
Lancet (London, England) 19840915
-
Orthostatic hypotension as a complication of hexamethylmelamine antidepressant interaction.
Cancer treatment reports 19830501
-
A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
Gynecologic oncology 19830401
-
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.
British journal of cancer 19830101
-
Hexamethylmelamine chemotherapy for disseminated endometrial cancer.
Obstetrics and gynecology 19810901
-
Single-agent chemotherapy for recurrent carcinoma of the cervix.
Cancer clinical trials 19800101
-
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
Cancer treatment reports 19790801
-
Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer.
American journal of obstetrics and gynecology 19790401
